Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète

The Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète (CERITD) is a French research organization dedicated to advancing diabetes care through technological innovation. Founded in 1988, the center is a pioneer in the development of the artificial pancreas and was instrumental in the creation of Diabeloop, an autonomous insulin delivery system. CERITD also developed the TELESAGE platform, a comprehensive telemedicine solution for remote monitoring and management of diabetic patients. The organization operates at the intersection of clinical research and medical engineering, focusing on reducing the therapeutic burden for patients while optimizing glycemic control. It maintains strong ties with the Centre Hospitalier Sud Francilien and various industrial partners to bring digital health solutions to the clinical market.